Considerations on Immunization and Immunosuppression of Patients With Autoimmune Blistering Diseases During COVID-19 Pandemic in Brazil: Case Report

Imagem de Miniatura
Arquivos
art_MIYAMOTO_Considerations_on_Immunization_and_Immunosuppression_of_Patients_With_2022.PDF (916.25 KB)
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2022
DOI
Scopus
Web of Science
PubMed
Título da Revista
ISSN da Revista
Título do Volume
Editora
FRONTIERS MEDIA SA
Autores
Citação
FRONTIERS IN MEDICINE, v.8, article ID 811562, 6p, 2022
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Autoimmune blistering diseases comprise a rare group of potentially life-threatening dermatoses. Management of autoimmune disorders poses a challenge in terms of achieving disease control and preventing adverse events. Treatment often requires an individualized approach considering disease severity, age, comorbidities, and infectious risk especially in the context of the ongoing COVID-19 pandemic. Knowledge regarding SARS-CoV-2 infection is still evolving and no specific antiviral therapy is available yet. We report four patients with active disease that required adjustment of treatment during the pandemic to discuss the use of immunosuppressants and immunobiologics, weighing potential risks and benefits of each therapy modality and vaccination status.
Palavras-chave
COVID-19, SARS-CoV-2, autoimmune blistering diseases, pemphigus, immunosuppressants, rituximab, vaccine
URI
https://observatorio.fm.usp.br/handle/OPI/47093
Referências
  1. Anuragi RP, 2020, DERMATOL THER, V33, DOI 10.1111/dth.14361
  2. Avancini J, 2021, J AM ACAD DERMATOL, V84, pE67, DOI 10.1016/j.jaad.2020.09.030
  3. Cozzani E, 2021, EUR J DERMATOL, V31, P415, DOI 10.1684/ejd.2021.4043
  4. Cugno M, 2016, THROMB HAEMOSTASIS, V115, P193, DOI 10.1160/TH15-04-0309
  5. Damiani G, 2021, J EUR ACAD DERMATOL, V35, pE645, DOI 10.1111/jdv.17472
  6. Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1
  7. Drenovska K, 2021, CLIN DERMATOL, V39, P359, DOI 10.1016/j.clindermatol.2021.01.007
  8. Gambichler T, 2022, BRIT J DERMATOL, V186, P728, DOI 10.1111/bjd.20890
  9. Hanan N, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9060596
  10. Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]
  11. Hwang E, 2021, BRIT J DERMATOL, V185, P1048, DOI 10.1111/bjd.20571
  12. Kasperkiewicz M, 2021, J EUR ACAD DERMATOL, V35, pE412, DOI 10.1111/jdv.17207
  13. Kasperkiewicz M, 2021, J AM ACAD DERMATOL, V84, P563, DOI 10.1016/j.jaad.2020.08.012
  14. Kato F, 2020, MICROBIOL IMMUNOL, V64, P635, DOI 10.1111/1348-0421.12828
  15. Kridin K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01559
  16. Kridin K, 2018, J DERMATOL, V45, P1094, DOI 10.1111/1346-8138.14503
  17. Lorenz Camila, 2021, Rev. bras. epidemiol., V24, pe210040, DOI 10.1590/1980-549720210040
  18. Mahmoudi H, 2021, J AM ACAD DERMATOL, V84, P1098, DOI 10.1016/j.jaad.2020.12.043
  19. Moor MB, 2021, LANCET RHEUMATOL, V3, pE789, DOI 10.1016/S2665-9913(21)00251-4
  20. Murrell DF, 2020, J AM ACAD DERMATOL, V82, P575, DOI 10.1016/j.jaad.2018.02.021
  21. Negri EM, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.573044
  22. Shakshouk H, 2021, J AM ACAD DERMATOL, V84, pE61, DOI 10.1016/j.jaad.2020.09.002
  23. Sokumbi O, 2013, J AM ACAD DERMATOL, V68, P36, DOI 10.1016/j.jaad.2012.07.003
  24. Solimani F, 2021, J EUR ACAD DERMATOL, V35, pE649, DOI 10.1111/jdv.17480
  25. Strangfeld A, 2021, ANN RHEUM DIS, V80, P930, DOI 10.1136/annrheumdis-2020-219498
  26. Sun QS, 2021, DERMATOL CLIN, V39, P639, DOI 10.1016/j.det.2021.05.014
  27. Thompson AE, 2020, JAMA INTERN MED, V180, P1537, DOI 10.1001/jamainternmed.2020.3030
  28. Vijenthira A, 2021, BLOOD ADV, V5, P2624, DOI 10.1182/bloodadvances.2021004629
  29. Wack S, 2021, J AM ACAD DERMATOL, V85, P1274, DOI 10.1016/j.jaad.2021.07.054
  30. Zwerner J, 2007, DERMATOL THER, V20, P229, DOI 10.1111/j.1529-8019.2007.00136.x

Coleções
Artigos e Materiais de Revistas Científicas - FM/MDT
Artigos e Materiais de Revistas Científicas - COVID-19
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/53
Artigos e Materiais de Revistas Científicas - LIM/56
Artigos e Materiais de Revistas Científicas - ODS/03
Carregar mais